These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 24857146)

  • 21. Treatment Algorithms Based on Tumor Molecular Profiling: The Essence of Precision Medicine Trials.
    Le Tourneau C; Kamal M; Tsimberidou AM; Bedard P; Pierron G; Callens C; Rouleau E; Vincent-Salomon A; Servant N; Alt M; Rouzier R; Paoletti X; Delattre O; Bièche I
    J Natl Cancer Inst; 2016 Apr; 108(4):. PubMed ID: 26598514
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current concepts in breast cancer genomics: An evidence based review by the CGC breast cancer working group.
    Geiersbach KB; Chen H; Emmadi R; Haskell GT; Lu X; Liu YJ; Swisshelm K
    Cancer Genet; 2020 Jun; 244():11-20. PubMed ID: 32087595
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Precision cancer medicine: the future is now, only better.
    Tsimberidou AM; Eggermont AM; Schilsky RL
    Am Soc Clin Oncol Educ Book; 2014; ():61-9. PubMed ID: 24857061
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genomic and transcriptional heterogeneity-based precision in personalized treatment for breast cancer.
    Antoniou P; Ziogas DE; Vlachioti A; Lykoudis EG; Mitsis M; Roukos DH
    Per Med; 2019 Sep; 16(5):361-364. PubMed ID: 31507233
    [No Abstract]   [Full Text] [Related]  

  • 25. Personalized medicine for metastatic breast cancer.
    Chen TW; Bedard PL
    Curr Opin Oncol; 2013 Nov; 25(6):615-24. PubMed ID: 24097103
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical Diagnosis and Management of Breast Cancer.
    McDonald ES; Clark AS; Tchou J; Zhang P; Freedman GM
    J Nucl Med; 2016 Feb; 57 Suppl 1():9S-16S. PubMed ID: 26834110
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insights into the theranostic value of precision medicine on advanced radiotherapy to breast cancer.
    Jiang M; Yang J; Li K; Liu J; Jing X; Tang M
    Int J Med Sci; 2021; 18(3):626-638. PubMed ID: 33437197
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Towards a personalized treatment of head and neck cancer.
    Gross AM; Cohen EE
    Am Soc Clin Oncol Educ Book; 2015; ():28-32. PubMed ID: 25993138
    [No Abstract]   [Full Text] [Related]  

  • 29. [Precision medicine: A major step forward in specific situations, a myth in refractory cancers?].
    Albin N; Mc Leer A; Sakhri L
    Bull Cancer; 2018 Apr; 105(4):375-396. PubMed ID: 29501208
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Steps forward for cancer precision medicine.
    Salgado R; Moore H; Martens JWM; Lively T; Malik S; McDermott U; Michiels S; Moscow JA; Tejpar S; McKee T; Lacombe D;
    Nat Rev Drug Discov; 2018 Jan; 17(1):1-2. PubMed ID: 29170471
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative genomic analysis of primary tumors and metastases in breast cancer.
    Bertucci F; Finetti P; Guille A; Adélaïde J; Garnier S; Carbuccia N; Monneur A; Charafe-Jauffret E; Goncalves A; Viens P; Birnbaum D; Chaffanet M
    Oncotarget; 2016 May; 7(19):27208-19. PubMed ID: 27028851
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genomic profiling of breast cancers.
    Curtis C
    Curr Opin Obstet Gynecol; 2015 Feb; 27(1):34-9. PubMed ID: 25502431
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Issues in clinical research for metastatic breast cancer.
    Dogan S; Andre F; Arnedos M
    Curr Opin Oncol; 2013 Nov; 25(6):625-9. PubMed ID: 24097109
    [TBL] [Abstract][Full Text] [Related]  

  • 34. National Cancer Institute's Precision Medicine Initiatives for the new National Clinical Trials Network.
    Abrams J; Conley B; Mooney M; Zwiebel J; Chen A; Welch JJ; Takebe N; Malik S; McShane L; Korn E; Williams M; Staudt L; Doroshow J
    Am Soc Clin Oncol Educ Book; 2014; ():71-6. PubMed ID: 24857062
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Successes and limitations of targeted cancer therapy in melanoma.
    Romano E; Michielin O
    Prog Tumor Res; 2014; 41():78-88. PubMed ID: 24727988
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A decision support framework for genomically informed investigational cancer therapy.
    Meric-Bernstam F; Johnson A; Holla V; Bailey AM; Brusco L; Chen K; Routbort M; Patel KP; Zeng J; Kopetz S; Davies MA; Piha-Paul SA; Hong DS; Eterovic AK; Tsimberidou AM; Broaddus R; Bernstam EV; Shaw KR; Mendelsohn J; Mills GB
    J Natl Cancer Inst; 2015 Jul; 107(7):. PubMed ID: 25863335
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Precision medicine in breast cancer.
    Naito Y; Urasaki T
    Chin Clin Oncol; 2018 Jun; 7(3):29. PubMed ID: 30056731
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeted Therapy of Breast Cancer.
    Janni W
    Oncol Res Treat; 2016; 39(3):100-1. PubMed ID: 27031668
    [No Abstract]   [Full Text] [Related]  

  • 39. Standard and Genomic Tools for Decision Support in Breast Cancer Treatment.
    Henry NL; Bedard PL; DeMichele A
    Am Soc Clin Oncol Educ Book; 2017; 37():106-115. PubMed ID: 28561710
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preparing pathology for precision medicine: challenges and opportunities.
    Kaul KL
    Virchows Arch; 2017 Aug; 471(2):141-146. PubMed ID: 28512674
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.